Case Study: Comparing Real-World Evidence to Clinical Trial Events at AstraZeneca

AstraZeneca set out to test the hypothesis that Real-World Evidence (RWE) adverse reaction information from patients could effectively supplement information from clinical trials, to give scientists and clinicians a more accurate, well-rounded description of safety data for particular treatments. The Linguamatics I2E text-mining solution played a key role in rapidly assembling comparable data sets.

Download the full case study, or access the webinar. You can also read more in our blog

AstraZeneca case study

Download the Case Study